Reuters logo
BRIEF-Reata Pharmaceuticals says top-line data to be available in 2019 for omaveloxolone​
2017年10月23日 / 中午11点43分 / 1 个月前

BRIEF-Reata Pharmaceuticals says top-line data to be available in 2019 for omaveloxolone​

Oct 23 (Reuters) - Reata Pharmaceuticals Inc-

* Reata Pharmaceuticals Inc - ‍announces first patient enrolled in Part 2 of Moxie study of omaveloxolone for treatment of Friedreich’s Ataxia​

* Reata Pharmaceuticals Inc - Reata expects top-line data to be available in second half of 2019 for omaveloxolone​ ‍​ Source text for Eikon: Further company coverage:

我们的标准:汤森路透“信任原则”
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below